EPISODE · Sep 12, 2026 · 9 MIN
Insulin Resistance Score + Tirzepatide Low-Dose Cycling: What It Is and Why It Matters
from CFP Weight Loss with Russell Clark · host Russell Clark, FNP-C
Insulin Resistance Score + Tirzepatide Low-Dose Cycling: What It Is and Why It Matters Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Insulin Resistance Score + Tirzepatide Low-Dose Cycling: What It Is and Why It Matters. ... I'm not here to sensationalize. We'll examine the topic through research, physiology, and practical clinical experience. ... We'll touch on Insulin Resistance Score, Tirzepatide Cycling, HOMA-IR Tracking — especially as they apply to real people over forty. ... Insulin resistance remains one of the most silent drivers of metabolic disease, weight regain, and chronic fatigue. The insulin resistance score—most commonly measured through HOMA-IR—quantifies how effectively your body responds to its own insulin. When paired with strategic low-dose tirzepatide cycling, this score becomes a powerful compass for true metabolic repair rather than temporary appetite suppression. ... The 30-Week Tirzepatide Reset . leverages this combination to move beyond conventional continuous GLP-1 use. By tracking HOMA-IR across structured 6-week-on, 4-week-off cycles, patients witness measurable improvements in insulin sensitivity that persist long after medication is paused. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/insulin-resistance-score-tirzepatide-cycling-low-dose-what-it-is-and-why-it-matt-4sbtc6
Embed this episode
Ready to play
Insulin Resistance Score + Tirzepatide Low-Dose Cycling: What It Is and Why It Matters
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.